Non-invasive Helicobacter Pylori Testing Market Size & Growth Forecast 2027–2036, By Segments (Test Type, End-user, Method), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Non-invasive Helicobacter Pylori Testing Market size was estimated at USD 326.18 Million in 2026 and is projected to grow at 7.53% CAGR from 2027 to 2036, crossing USD 674.15 Million by 2036. The industry revenue for 2027 is assessed at USD 347.02 Million.
Get more details on this report
Request Free Sample ReportNon-invasive Helicobacter Pylori Testing Market Intelligence Snapshot
Regional Market Dynamics
- North America held 38.56% in 2026, supported by established diagnostic infrastructure, high awareness, accessible testing methods, and emphasis on early detection.
- Asia Pacific is expanding rapidly through improving diagnostic infrastructure, healthcare awareness, preventive care adoption, and wider access to convenient testing technologies.
Segment Momentum
- The serologic test segment held 42.93% share in 2026 due to its simplicity, accessibility, and suitability for large-scale screening with minimal patient discomfort.
- Point-of-care tests are expanding as healthcare providers seek faster diagnosis, decentralized testing options, and improved patient convenience for timely clinical decisions.
Market Expansion Drivers
- Rising gastric and duodenal disease burden driving demand for non-invasive diagnostic testing solutions
- Growing adoption of point-of-care diagnostics improving early H. pylori detection and treatment outcomes
- Advancements in serological assay technologies enhancing diagnostic accuracy and testing efficiency
Leading Market Participants
- Top players in the non-invasive helicobacter pylori testing market include Abbott Laboratories (USA), Bio-Rad Laboratories Inc. (USA), QuidelOrtho Corporation (USA), Meridian Bioscience Inc. (USA), Thermo Fisher Scientific Inc. (USA), Biohit Oyj (Finland), Cardinal Health Inc. (USA), Qiagen N.V. (Germany), Sekisui Diagnostics LLC (Japan), DiaSorin S.p.A. (Italy)
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 326.18 Million
- 2027 Estimated Market Size: USD 347.02 Million
- Projected Market Size: USD 674.15 Million by 2036
- Growth Forecast: 7.53% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Serologic Test (Test Type) | Diagnostic Laboratories (End-user) | Laboratory Based Test (Method)
- Emerging Opportunity Segment: Serologic Test (Test Type) | Diagnostic Laboratories (End-user) | Point of Care (POC) Test (Method)
Market Growth Drivers and Industry Trends
Rising gastric and duodenal disease burden driving demand for non-invasive diagnostic testing solutions
The increasing prevalence of gastric and duodenal disorders is strengthening the need for accurate and patient-friendly diagnostic methods, a trend that will drive the non-invasive helicobacter pylori testing market growth. Healthcare providers are increasingly utilizing non-invasive testing approaches to identify *helicobacter pylori* infections without exposing patients to invasive diagnostic procedures. These methods improve patient comfort while supporting timely clinical decision-making for individuals presenting with gastrointestinal symptoms. Their suitability for routine screening, follow-up assessments, and large-scale testing programs has contributed to wider adoption across hospitals, diagnostic laboratories, and outpatient healthcare facilities.
Growing adoption of point-of-care diagnostics improving early H. pylori detection and treatment outcomes
The expanding use of decentralized diagnostic technologies is creating favorable opportunities that will propel the non-invasive helicobacter pylori testing market growth by enabling faster identification of infections in diverse healthcare environments. Point-of-care testing supports rapid clinical assessment, allowing healthcare professionals to initiate appropriate treatment strategies without prolonged diagnostic delays. This capability is particularly valuable in primary care settings, community health centers, and regions where access to advanced laboratory infrastructure may be limited. Earlier diagnosis also facilitates more effective disease management by supporting timely therapeutic intervention and improved monitoring of treatment response.
Advancements in serological assay technologies enhancing diagnostic accuracy and testing efficiency
Ongoing improvements in immunodiagnostic technologies are increasing the reliability of laboratory testing, and the non-invasive helicobacter pylori testing market demand is expanding as more accurate serological assays become available. Modern assay platforms offer enhanced sensitivity, specificity, and streamlined laboratory workflows that support efficient processing of large testing volumes. Technological refinements in reagent development, automated analysis systems, and quality control procedures are improving consistency across diagnostic laboratories while reducing turnaround times. These innovations strengthen confidence among clinicians by providing dependable diagnostic information that supports informed treatment planning and patient management.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising gastric and duodenal disease burden driving demand for non-invasive diagnostic testing solutions | 2% | High | North America, Europe | High | Near Term |
| Growing adoption of point-of-care diagnostics improving early H. pylori detection and treatment outcomes | 1.8% | High | Asia Pacific, Europe | High | Near Term |
| Advancements in serological assay technologies enhancing diagnostic accuracy and testing efficiency | 1.5% | Moderate | North America, Asia Pacific | Emerging | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
North America accounted for the largest share of the non-invasive helicobacter pylori testing market, representing 38.56% in 2026. The region's strong position is supported by established diagnostic infrastructure, high awareness of gastrointestinal disorders, and broad availability of non-invasive testing methods. Increasing recognition of the role of helicobacter pylori infection in peptic ulcer disease and other gastrointestinal conditions is encouraging timely diagnosis and follow-up testing. Healthcare providers are also increasingly favoring diagnostic approaches that reduce patient discomfort and avoid invasive procedures, supporting the use of breath- and stool-based testing. Established healthcare systems, access to advanced diagnostic facilities, and emphasis on early detection further contribute to regional demand.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is expected to register the fastest growth in the non-invasive helicobacter pylori testing market, driven by increasing healthcare awareness, improving diagnostic infrastructure, and the substantial burden of gastrointestinal infections across the region. Expanding access to hospitals, laboratories, and specialized diagnostic services is making non-invasive testing more accessible, particularly in developing healthcare markets. Growing adoption of preventive healthcare and increasing patient awareness of gastrointestinal health are also encouraging individuals to seek diagnosis and treatment earlier. In addition, improvements in healthcare expenditure and the wider availability of convenient diagnostic technologies are creating favorable conditions for greater utilization of helicobacter pylori testing.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
United States 🇺🇸
Diagnostic Workflow OptimizationThe U.S. continues expanding the use of non-invasive Helicobacter pylori testing within outpatient gastroenterology and primary care. Demand centers on accurate diagnosis, treatment monitoring, and reducing reliance on invasive diagnostic procedures where appropriate.
Germany 🇩🇪
Laboratory Quality FocusGermany emphasizes high-quality laboratory diagnostics and standardized non-invasive Helicobacter pylori testing protocols. Clinical practice increasingly favors reliable testing methods that support antimicrobial stewardship and appropriate treatment decisions.
Japan 🇯🇵
Routine Screening SupportJapan maintains strong clinical attention to gastric disease prevention, encouraging broader use of non-invasive Helicobacter pylori testing. Healthcare providers continue refining diagnostic pathways that enable timely identification and post-treatment confirmation.
South Korea 🇰🇷
Preventive Diagnostics PrioritySouth Korea supports wider adoption of non-invasive Helicobacter pylori testing through preventive healthcare initiatives and advanced diagnostic infrastructure. Clinical demand favors rapid, patient-friendly testing options suitable for routine evaluation.
France 🇫🇷
Evidence-Based TestingFrance promotes evidence-based use of non-invasive Helicobacter pylori testing to improve diagnostic efficiency and patient management. Healthcare providers increasingly incorporate validated testing methods into gastrointestinal care pathways.
Italy 🇮🇹
Gastroenterology Practice EnhancementItaly continues strengthening gastroenterology services through greater use of non-invasive Helicobacter pylori testing. Clinical priorities focus on improving patient comfort while supporting accurate diagnosis and treatment follow-up.
Segment Leadership and Growth Trends
Non-invasive Helicobacter Pylori Testing Market Share (%), by Test Type, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportTest Type Segment Analysis: Serologic Test (Largest & Fastest-Growing Segment)
The non-invasive helicobacter pylori testing market was led by the serologic test segment, which accounted for 42.93% of the market share in 2026 while also emerging as the fastest-growing test type. Serologic testing is widely utilized because it is simple to perform, readily accessible, and suitable for large-scale screening across diverse healthcare settings. Its ability to support early clinical assessment with minimal patient discomfort has encouraged broad adoption. Continued efforts to improve gastrointestinal disease diagnosis and expand access to non-invasive testing solutions are expected to reinforce both the segment's market leadership and growth.
End-user Segment Analysis: Diagnostic Laboratories (Largest & Fastest-Growing Segment)
The diagnostic laboratories segment dominated the non-invasive helicobacter pylori testing market, accounting for 46.32% of the market share in 2026, while also representing the fastest-growing end-user category. Diagnostic laboratories possess the specialized infrastructure, skilled personnel, and quality assurance systems necessary to perform high volumes of non-invasive gastrointestinal diagnostic tests with consistent accuracy. Rising demand for reliable laboratory diagnostics, together with increasing physician referrals and expanding preventive healthcare initiatives, continues to strengthen the segment's leading position.
Method Segment Analysis: Laboratory Based Test (Largest Segment) vs Point of Care (POC) Test (Fastest-Growing Segment)
The laboratory based test segment held the largest share of the non-invasive helicobacter pylori testing market in 2026. Laboratory-based methods remain the preferred approach because they provide standardized testing procedures, reliable analytical performance, and the capacity to process large sample volumes efficiently. Their widespread availability within established healthcare systems has supported continued market leadership.
The point of care (POC) test segment is anticipated to witness the fastest growth as healthcare providers increasingly seek rapid diagnostic solutions that enable timely clinical decision-making. The growing emphasis on decentralized healthcare delivery, improved patient convenience, and faster diagnosis is driving wider adoption of point-of-care testing technologies. Continued innovation in portable diagnostic platforms is expected to further accelerate growth within this segment.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Test Type | Serologic Test, Urea Breath Test, Stool/fecal Antigen Test | Serologic Test | Serologic Test |
| End-user | Hospitals, Clinics, Diagnostic Laboratories, Others | Diagnostic Laboratories | Diagnostic Laboratories |
| Method | Laboratory Based Test, Point of Care (POC) Test | Laboratory Based Test | Point of Care (POC) Test |
Competitive Landscape and Market Positioning
Prominent players in the non-invasive helicobacter pylori testing market:
- Abbott Laboratories (USA)
- Bio-Rad Laboratories, Inc. (USA)
- QuidelOrtho Corporation (USA)
- Meridian Bioscience, Inc. (USA)
- Thermo Fisher Scientific, Inc. (USA)
- Biohit Oyj (Finland)
- Cardinal Health, Inc. (USA)
- Qiagen N.V. (Germany)
- Sekisui Diagnostics LLC (Japan)
- DiaSorin S.p.A. (Italy)
Competitive dynamics in the Non-invasive Helicobacter Pylori Testing Market are being shaped by the demand for faster, more convenient, and reliable diagnostic approaches that reduce dependence on invasive procedures. Providers are focusing on improving test sensitivity, ease of use, and integration into routine healthcare screening workflows as diagnostic adoption expands. Competition is increasingly centered on technological refinement and the ability to deliver accurate results across diverse healthcare settings, including decentralized and outpatient environments. Regulatory compliance, clinical acceptance, and cost-effective deployment are becoming key factors determining which testing solutions gain wider adoption among healthcare providers.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories (USA) | |||||||
| Bio-Rad Laboratories Inc. (USA) | |||||||
| QuidelOrtho Corporation (USA) | |||||||
| Meridian Bioscience Inc. (USA) | |||||||
| Thermo Fisher Scientific Inc. (USA) | |||||||
| Biohit Oyj (Finland) | |||||||
| Cardinal Health Inc. (USA) | |||||||
| Qiagen N.V. (Germany) | |||||||
| Sekisui Diagnostics LLC (Japan) | |||||||
| DiaSorin S.p.A. (Italy) |
Industry Development/News
| Company Name | Date | Key Development |
|---|
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Non-invasive Helicobacter Pylori Testing Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Clinical Indication | Initial Diagnosis, Test of Cure, Recurrent Infection Assessment, Screening of High-Risk Patients |
| Patient Age Group | Pediatric Patients, Adults, Older Adults |
| Payer Type | Public Healthcare Payers, Private Insurance, Self-Pay |
Non-invasive Helicobacter Pylori Testing Market — Custom TOC
| Custom Chapter | Custom Details |
|---|---|
| Diagnostic Pathway Optimization Assessment |
|
| Point-of-Care Testing Adoption Outlook |
|
| Screening Program and Public Health Opportunity Analysis |
|
Need a different cut of the data?
Request Custom ResearchHow much is the non-invasive helicobacter pylori testing market worth?
How is the non-invasive helicobacter pylori testing industry expected to grow over the next 10 years?
Why is demand increasing for non-invasive Helicobacter pylori testing solutions?
How are point-of-care and assay advancements strengthening the non-invasive Helicobacter pylori testing market?
Why does the serologic test segment lead the non-invasive Helicobacter pylori testing market?
How are point-of-care tests gaining momentum in this market?
What makes North America the leading market for non-invasive Helicobacter pylori testing?
Why is Asia Pacific expected to see the fastest growth in non-invasive Helicobacter pylori testing?
What are the key competitors in the non-invasive helicobacter pylori testing landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization